Recent News

Radiation Does Not Improve Survival in Pleural Mesothelioma Patients

August 13, 2021

A study at the Duke University Medical Center has found that radiation does not extend survival in pleural mesothelioma patients. A dual registry analysis was performed to determine the effectiveness[…]

ONCOFID-P Was Given Orphan Drug Status to Treat Pleural Mesothelioma

August 6, 2021

Pleural mesothelioma could soon have a new approved treatment option. The Food and Drug Administration just granted orphan drug status to ONCOFID-P for the treatment of the cancer. It is[…]

Researchers are Trying to Find New Treatments to Combine with Tumor Treating Fields

July 30, 2021

Tumor Treating Fields were approved for treating mesothelioma, and while they are effective, researchers want to make them more effective for the cancer. A researcher at the Humanitas University in[…]

CAR-T Cell Therapy and Keytruda is Showing Real Promise

July 23, 2021

Researchers at the Memorial Sloan Kettering Cancer Center are experimenting with a combination of CAR-T cell therapy and Keytruda, a PD-1 blocker for the treatment of pleural mesothelioma. This is[…]

A New Predictive Model Could Help Doctors Choose the Best Surgery for Mesothelioma Patients

July 16, 2021

Doctors could soon pick the best surgery for pleural mesothelioma patients because of a new predictive model created by Harvard researchers. There are different types of mesothelioma surgery: one involves[…]

Immunotherapy Treatment for Mesothelioma Could Become Safer and More Effective

July 9, 2021

Research could help create better and safer immunotherapy treatments for mesothelioma. Immunotherapy is a fast growing and exciting way to treat cancer because it uses the body’s own immune system[…]

GPS Vaccine is Effective in Mesothelioma Patients When Paired with Opdivo

July 2, 2021

A new cancer vaccine was found to be effective in mesothelioma patients alongside Opdivo in a new study. It was studied in people whose cancer no longer responded to standard[…]

Vinorelbine Could Soon be Used to Treat Mesothelioma

June 25, 2021

Vinorelbine could be a useful second-line treatment for patients with relapsed mesothelioma. A phase II clinical trial examined vinorelbine to see how effective it is in patients who had their[…]

Pleural Effusion in Mesothelioma Patients May Affect Survival

June 18, 2021

Pleural effusion may affect mesothelioma survival. Pleural effusion is a buildup of fluid around the lungs that can be caused by multiple illnesses including heart failure, kidney and liver disease,[…]

Adjuvant Radiotherapy Does Not Improve Survival in Pleural Mesothelioma Patients

June 11, 2021

Adjuvant radiotherapy might not be the best treatment for mesothelioma sufferers because researchers at Duke and Stanford found that this therapy does not help patients live longer. The researchers analyzed[…]

Skip to content